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In both Type I and Type II diabetes, a loss of functioning beta cells results in an 
inability to produce insulin effectively to regulate blood glucose. Current treatments have 
a variety of problems including insulin-dependence, donor scarcity, comorbidities, and 
cost. We are interested in inducing the body to produce its own beta cells endogenously 
by either neogenesis from progenitors or proliferation of existing beta cells. From 
previous work, we know that the transcription factor Sox9b plays an important role in the 
identity of endocrine progenitor cells in the zebrafish pancreas, known as centroacinar 
cells (CACs), that contribute to regeneration of beta cells. Since humans also have CACs 
but do not regenerate efficiently, we wanted to understand the downstream targets of 
Sox9b/SOX9 and their role in the biology of CACs. Using RNA-seq and ChIP-seq in 
PANC-1 cells we were able to find direct targets of SOX9, including the interesting 
candidate EPCAM, to follow up on. For assessing beta-cell proliferation, we knew from a 
previous screen that selective serotonin reuptake inhibitors (SSRIs) can induce beta-cell 
proliferation in the larval zebrafish. We hypothesized that innervation of the principal 
islet was responsible for this serotonergic signaling to the pancreas. Using imaging of a 
variety of transgenic lines, we established that innervation of the islet occurs by 4 days 
post fertilization and that the sox10 mutant zebrafish has a reduced amount of this 
innervation. When treated with the SSRI paroxetine (Paxil), we saw that sox10 mutant 
fish still had an increase in beta-cell proliferation (compared to DMSO control). This 
suggests that innervation is in fact not necessary for serotonergic signaling to the 
pancreas and there must be another source of serotonin production and transport. Our 
better understanding of both the molecular mechanisms behind CAC differentiation into 
	iii 
new beta cells and the proliferation of beta cells induced by serotonin signaling will help 
inform new and better treatments of diabetes. 
 




A big thank you to Sarah McClymont, Rebecca Beer, PhD, and Frazer Matthews 
for their help with data collection and analysis in the collaborative effort described in Part 
I. 
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 Diabetes is a world-wide health issue – as of 2013, 382 million people suffer from 
the disease, presenting a huge burden on economic and healthcare systems.1 The 
downstream health issues of the hyperglycemia induced by diabetes include serious 
problems like diabetic ketoacidosis, retinopathy and neuropathy, kidney disease, heart 
disease, and a general decrease in lifespan.1 Both Type I and Type II diabetes are diseases 
of hyperglycemia caused by the dysregulation of blood sugar control. Normally, the beta 
cells of the pancreas respond to a post-prandial increase in blood sugar by releasing 
insulin. Insulin acts on other tissues in the body to decrease blood glucose – it stops 
adipocytes from lipolysis, stops the liver from gluconeogenesis, and induces muscle 
tissue to take up sugar from the blood for storage.2 Type I diabetes is an autoimmune 
disease in which beta cells are destroyed early on in life and therefore patients require an 
outside source of insulin in order to control their blood sugar.3 In Type II diabetes, tissues 
develop insulin resistance and in later stages there is also a loss of functional beta cells.2,4 
Therefore in both cases, a treatment is needed that increases beta-cell mass so that 
patients are not insulin-dependent. 
 The first and most widely-used treatment when there is a loss of beta cells is 
injectable insulin. This is generally managed through a basal injection of long-acting 
insulin and then multiple bolus injections of shorter-acting insulin after meals.5 Delivery 
of exogenous insulin can also be achieved using an insulin pump, where a pump is worn 
continuously and insulin is received by a subcutaneous cannula. While exogenous insulin 
does prevent hyperglycemia, it requires patients to either receive multiple injections per 
day or constantly wear an insulin pump.6 In addition, determining when to receive insulin 
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(and how much to receive) means a lot of education of patients (and their parents in the 
case of children with Type I diabetes) and requires patients to stay engaged in their 
treatment for a lifetime. If too much insulin is received, it can cause serious 
hypoglycemia. Finally, exogenous insulin is not a “cure” for diabetes in that patients still 
do not have enough functioning beta cells.   
 In order to try to prevent dependence on exogenous insulin, transplants of either 
the whole pancreas from a donor or of just islet cells (from multiple donors) are 
becoming more common. With both options, patients can become insulin independent, 
although this is more common when transplanting the whole pancreas. Although these 
treatments offer a more sustainable “cure” to loss of beta cells than insulin injections, 
they come with their own difficulties. First and foremost, transplantation comes with a 
donor scarcity problem, especially in the case of islet cells which need to come from 
multiple deceased donors to treat one patient. In addition, transplantation requires 
lifelong immunosuppression and the surgeries themselves have associated morbidity, 
especially for whole-organ transplantation.7,8 
 Finally, there is research moving towards using stem-cell derived beta cells as a 
treatment for diabetes. The company ViaCyte is using human embryonic stem cell-
derived pancreatic endoderm (hES-PE) within a microencapsulation device that can be 
implanted subcutaneously. This device allows for the flow of glucose in and insulin out, 
but prevents entrance of immune cells so immunosuppression is not required. The hES-
PE includes beta-cell-like cells that can respond to blood sugar effectively in mice.9,10 
These devices are currently in human clinical trials but are having difficulty with 
successful engraftment. 
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 Because each of the current treatment options for beta-cell loss has a range of 
challenges, the optimal way to treat the beta-cell loss associated with diabetes would be 
to induce the body to endogenously make more beta cells. This would result in insulin 
independence, as well as avoid the morbidities associated with transplantation and the 
cost of differentiating stem cells. Neogenesis, the production of new beta cells from 
progenitor cells, and proliferation of existing beta cells are two ways in which the body 
can increase beta-cell mass. In order to induce the endogenous creation of more beta 
cells, we need to better understand the pathways behind neogenesis and proliferation.  
 The zebrafish is an excellent model system for studying the mechanisms driving 
beta-cell neogenesis and proliferation. The morphology of the adult zebrafish pancreas is 
very similar to that of mammals. Both have the acinar cells of the exocrine pancreas 
(responsible for synthesizing and secreting digestive enzymes) organized in acini. Ducts, 
lined by ductal cells, carry these enzymes to the gut. A subset of duct cells known as 
centroacinar cells (CACs), which will be discussed in more detail in Part I, exist in both 
zebrafish and mammals.11 Islets of endocrine cells, including beta cells, exist between 
acini – these islets, like in humans, have a core of beta cells surrounded by alpha, delta, 
and epsilon cells.12 The larval zebrafish pancreas also has these same cell types – acinar 
cells, ductal cells, and endocrine cells (organized in the principal and secondary islets).11 
 Similar molecular pathways also exist in the zebrafish and mammalian pancreas. 
The development of the mammalian and zebrafish pancreas involves very similar stages – 
specification of pancreas from foregut endoderm by transcription factors like PTF1A and 
PDX1 and involvement of the FGF10 and Notch signaling pathways in fate 
determination, for example.13,14 Ductal cells express SOX9 (or Sox9b) in both the 
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mammalian and zebrafish pancreas.15-17 In addition, RNA-seq work comparing the 
transcriptomes of pancreatic cells in zebrafish, mice, and humans found that there are 
overlapping core groups of genes that determine the identity and functions of endocrine 
cells in all three species.18 Because of the similar morphology and molecular 
underpinnings of the pancreas in zebrafish compared to mammals, we can use the 
zebrafish to study the mechanisms behind beta-cell neogenesis and proliferation to find 






















Ultimately, both Type I and Type II diabetes result in a loss of functioning beta-
cells. Current treatments, including insulin injections, transplantation of donor beta cells, 
and differentiation of stem cells are compromised by systemic complications, scarcity of 
donor tissues, and cost, respectively. An effective treatment for these diseases would 
ideally involve an increase in beta-cell mass. Thus exploring the induction of beta-cells 
endogenously from pancreatic progenitors is an alluring treatment target. However, the 
capacity for beta-cell neogenesis in mammals is controversial. Neogenesis of beta cells 
after partial ductal ligation has been seen in mice in some studies but not others,15,19-23 
and targeted ablation of beta cells in mice is resolved by proliferation and 
transdifferentiation.24-28 Analysis of islets of adult humans with Type I diabetes that died 
from diabetic ketoacidosis showed that while beta cells continuously apoptosed, there 
remained beta cells present at death and no markers of proliferation, suggesting some 
capacity for neogenesis.29,30 Conversely, zebrafish have an extraordinary capacity to 
regenerate beta cells by neogenesis after targeted ablation31,32 and we have identified the 
progenitor cell that contributes to beta-cell neogenesis in the zebrafish: centroacinar cells 
(CACs).33   
CACs are terminal intercalated duct cells – they exist in acini, have long 
extensions, are connected by tight junctions so they can successfully line pancreatic 
ducts, and are Notch responsive.11,33 In addition, they are known to express sox9b, a 
homologue of human SOX9, and we have shown that following beta-cell ablation, these 
sox9b-expressing CACs are a source of regenerated beta cells.34 Humans also have CACs 
- terminal intercalated duct cells that express SOX916 and are Notch responsive35  - but 
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their role in beta-cell neogenesis is unknown. Given the similarities between these cells in 
humans and zebrafish, by understanding the mechanisms behind beta-cell neogenesis via 
CACs in zebrafish, we may be able to exploit these same mechanisms in humans for use 
in diabetes treatment. 
Towards this end, an intriguing target to begin unravelling the mechanisms of 
beta-cell regeneration is SOX9. The importance of SOX9 in pancreatic identity36, ductal 
cell identity37, and pancreatic progenitor identity16 has already been established in 
mammals. Additionally, we recently found that Sox9b helps maintain the progenitor 
identity of CACs in zebrafish in that heterozygous loss of sox9b results in more efficient 
differentiation of CACs into beta cells after ablation34. Given its important role in 
pancreatic progenitor status across species, we are interested in understanding the 
transcriptional targets of SOX9 (and Sox9b) to elucidate the genetic program behind 
pancreatic progenitors and beta-cell neogenesis.  
We set out to identify effectors of SOX9 transcriptional activity in human 
pancreatic cells to reveal molecular mechanisms that drive beta-cell neogenesis using 
high-throughput sequencing methods. To do so, we utilized a human pancreatic 
adenocarcinoma line, PANC-1, that represents an undifferentiated, ductal pancreas cell 
population that can be induced to differentiate toward an endocrine fate.38 To query the 
mechanisms of SOX9 regulation in these cells, we integrated RNA-seq and ChIP-seq to 
identify direct transcriptional targets of SOX9. We found that SOX9 directly regulates 
EPCAM, which encodes a transmembrane protein expressed in stem and progenitor cells 
in many epithelial tissues39-42 and is an interesting target of future studies about 
pancreatic progenitor function. 
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MATERIALS AND METHODS 
RNA-seq library preparation and sequencing 
PANC-1 cells were transfected in 24-well plates with either 25 nM of control siRNA 
(Dharmacon catalog # D-001210-03-05) or 25 nM of SOX9 siRNA (Dharmacon catalog # 
M-021507-00-0005) using Lipofectamine 3000 (Thermo). After 48 hours, transfected 
cells were pooled (4 wells per replicate) and harvested, two replicates from each siRNA 
condition, and total RNA was isolated using a Qiagen RNeasy kit. RNA-seq libraries 
were created using the Illumina TruSeq Stranded Total RNA Sample Prep Kit. RNA-seq 
libraries were pooled and sequenced on the Illumina HiSeq 2000 to a minimum depth of 
60 million 2x100 bp reads per library. 
 
RNA-seq alignment, quantification, and analysis 
Reads were aligned to hg19 genome with HISAT2 (v2.0.5)43 and visualized with the 
Integrative Genomics Viewer.44,45 Statistical analyses were performed using R (R Core 
Team, 2017). Gene expression was quantified using the “featureCount” function of the 
Rsubread package (v1.28.1)46 to count read overlap with RefSeq genes. Genes with 
greater than one read across all four samples were submitted to DESeq2 (v1.18.1)47 to 
identify genes differentially expressed across conditions (absolute(log2(foldchange)) > 1, 
adjusted p-value < 0.05). To generate the volcano plot, each gene’s log2(fold change) was 
plotted against the –log10(adjusted p-value), with genes meeting our criteria for 
significantly differentially expressed being plotted in red (upregulated) or blue 
(downregulated). Genes significantly up- and down-regulated were submitted to 
Enrichr48,49. The GO Biological Process was ranked on the basis of the combined score. 
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Differentially expressed genes were annotated as being directly bound by SOX9 if there 
was a SOX9 binding event within 1kb (upstream or downstream) of the transcriptional 
start site (RefSeq, hg19).  
 
ChIP-seq library preparation and sequencing 
PANC-1 cells were grown in DMEM supplemented with 10% FBS at 37°C with 5.0% 
CO2 and passaged at 70-80% confluency. 2 biological replicates of ChIP-seq were 
performed essentially as in Lee et al., 2006.50 Briefly; approximately 2.0 X 108 cells were 
crosslinked in 11% formaldehyde and stopped with 2.5 M glycine before being washed in 
1X PBS, lysed, and sonicated for 35 minutes in a Bioruptor at 4°C to achieve a fragment 
size of approximately 200 bp. An input fraction was set aside and the rest of the lysate 
was then incubated with 10 ug anti-SOX9 (AB5535, Millipore) overnight at 4°C. 
Antibody-bound chromatin was then purified using Protein G Dynabeads (Thermo) and 
crosslinking was reversed overnight at 65°C. ChIP-seq libraries were created using the 
Illumina TruSeq DNA Sample Prep Kit and quantified using Quant-iT PicoGreen dsDNA 
assay (Invitrogen). ChIP-seq libraries were pooled and sequenced on the Illumina HiSeq 
to a minimum depth of 59 million, 1x50bp reads per library.   
 
ChIP-seq alignment, peak calling, and analysis 
Reads were aligned to hg19 with Bowtie2 (v2.2.5)51 in --local mode following TruSeq 
adapter removal and quality filtering with fastx toolkit (v0.0.14). Following alignment, 
reads with mapping score < MAPQ30, reads aligning to the mitochondria, and duplicate 
reads were removed with SAMtools (v1.3.1).52 ChIP-seq replicates were combined and 
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peaks were called on this joint file with MACS2 (v2.1.1.20160309)53 using “callpeak”. 
Peaks with q-value >10-3 and those overlapping ENCODE blacklists were removed.54 
These peaks were annotated for their genomic location using CEAS (v1.0.0)55 of the 
Cistrome analysis pipeline56 and the distance of each peak to the nearest gene’s 
transcriptional start site was quantified. The top 1000 most significant SOX9 peaks by q-
value were submitted to SeqPos (v1.0.0) under default parameters. The top resulting 
position weight matrices were matched to motifs in the JASPAR database.57 These same 
1000 peaks were submitted to GREAT (v3.0.0)58 under default settings except that the 
association rule was expanded such that “proximal” was defined as 5kb both upstream 
and downstream. The top 20 GO Biological Process terms by binomial rank were chosen 
for display and manually grouped by function. 
 
Western blot confirmation of SOX9 knockdown 
PANC-1 cells were cultured in 6-well plates and transfected with 100 nM control siRNA 
(catalogue number above) or 100 nM SOX9 siRNA (catalogue number above). After 48 
hours, cells were washed with PBS, isolated in RIPA buffer with complete, EDTA-free 
protease inhibitor (Roche) and vortexed. Supernatant was collected after centrifugation. 
Protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo 
Scientific) and 10 ug of protein was run on an Any kD Mini-PROTEAN TGX Precast 
Protein Gel (Bio-Rad). Transferred at 45V for 90 minutes. Membrane blocked for 1 hour 
and incubated overnight in primary antibody (Rabbit anti-Sox9 Santa Cruz sc-20095 
1:500; N-Cadherin D4R1H XP Rabbit mAb Cell Signaling Technology 13116 1:1000; E-
Cadherin 24E10 Rabbit mAb Cell Signaling Technology 3195 1:1000), washed 3 times, 
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and incubated in anti-rabbit HRP (Cell Signaling 7074S 1:2500) for 1 hour. Developed 
using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific) and 
exposed on a ChemiDoc-It2. Stripped membrane using Restore Western Blot Stripping 
Buffer (Thermo Scientific) and repeated staining and development as above using rabbit 
anti-beta-tubulin (Cell Signaling 2128 1:1000) primary.  
 
Antibody staining 
PANC-1 cells were grown on gelatin-coated coverslips for 48 hours after siRNA 
transfection and fixed in 4% paraformaldehyde buffered in 1X PBS. Following 4X5 min 
washes in 1X PBS, coverslips were blocked in PBST + 10% FBS for 1 hour at room 
temperature and permeablized in 0.5% Triton in PBS for 20 minutes, incubated with 
primary antibodies (rabbit anti-SOX9 Santa Cruz sc-20095 1:250; mouse anti-EPCAM 
Santa Cruz sc-66020 1:100; vimentin D21H3 XP Rabbit mAb Cell Signaling Technology 
5741 1:100) at 4°C overnight. Coverslips were washed 4X5 min in blocking, then 
incubated in secondary antibody (Alexa Fluor 488 donkey anti-rabbit, Alexa Fluor 488 
donkey anti-mouse, Cy3 donkey anti-rabbit, Alexa Fluor 647 donkey anti-rabbit, all 
1:500, Jackson ImmunoResearch 711-546-152, 715-456-150, 711-166-152, 711-606-152 
respectively) at 4°C overnight before 4X5 min final PBST washes and a brief DAPI 
(1:2500 in PBS) stain. Images were collected using a Nikon A1-si Laser Scanning 
Confocal microscope.  
 
Quantitative PCR confirmation of differentially expressed genes 
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PANC-1 cells were cultured in 12-well plates and transfected with 100 nM control 
siRNA (catalogue number above) or 100 nM SOX9 siRNA (catalogue number above). 
After 48 hours, RNA was isolated using Qiagen RNeasy Kit (with DNase digestion step) 
and cDNA was synthesized using Superscript III (Thermo) with random hexamer 
primers. 3 biological replicates of the quantitative PCR reactions were run in technical 
triplicate following the default SYBR green cycling conditions on an Applied Biosystems 
Viia 7 using 2x Power SYBR Green Master Mix (Applied Biosystems). Expression was 
calculated using the ΔΔCT method normalized to GAPDH expression and control siRNA 
transfected cells. Primer sequences can be found in Supplemental Table 2.59-61  
 
Correlation with TCGA pancreatic adenocarcinoma expression patterns 
mRNA-sequencing from 178 pancreatic adenocarcinoma samples from the TCGA was 
accessed and downloaded on March 2, 2018. Read-counts were log2 normalized after 
addition of a pseudocount and a heatmap (Raivo Kolde, 2015) was generated for all 
significantly upregulated and downregulated genes and SOX9’s expression patterns in 
these samples, using hierarchical clustering to group these selected genes into three 
clusters, and scaling the expression values by column. Individual gene correlation with 
SOX9 expression was calculated using the Pearson correlation method and for 
visualization, normalized expression values were plotted.  
 
Phenotypic characterization of epcam mutants 
Zebrafish were maintained in system water according to standard methods (Westerfield, 
2007). All work involving zebrafish was reviewed and pre-approved by the institutional 
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care and use committee. CRISPR-generated epcam heterozygotes (jh79) were bred with 
the following previously described lines: Tg(ela:GFP), Tg(tp1:GFP),62 and 
Tg(NeuroD:GFP).63 The resulting offspring were raised to adulthood and genotyped for 
epcam heterozygosity. Fish were in-crossed and embryos were maintained in E3 media 
(Westerfield, 2007). At 2 dpf the embryos were phenotyped and sorted by small otoliths 
(epcam mutant) and normal otoliths (epcam heterozygotes and wildtypes). For examining 
pancreas morphology, at 4 days dpf the larvae were fixed in 4% paraformaldehyde (PFA) 
for 48 hours at 4 °C and then imaged in methylcellulose on a Nikon AZ100 microscope. 
For examining CAC morphology, the midbodies of the larvae (heads digested for 
genotyping to confirm otolith phenotype) were fixed at 5 dpf in 4% PFA for at least 24 
hours at 4 °C. The gut with the pancreas attached was dissected out of each of the fixed 
larvae. These dissected samples were dehydrated, rehydrated, blocked, stained, mounted, 
and imaged as per Part II (rabbit anti-GFP Invitrogen A11122 1:400; Alexa Fluor 488 
donkey anti-rabbit Jackson ImmunoResearch 711-546-152 1:200). CACs were counted 
from these images using ImageJ. For examining CAC differentiation, larvae were treated 
from 3 to 5 dpf in either 0.5% DMSO (diluted from 100% stock) or 0.625 uM 
RO4929097 (Selleckchem S1575, diluted from 10 mM stock in DMSO) in E3. 
Midbodies of larvae were fixed at 5 dpf (heads digested to confirm genotype of otolith 




SOX9 modulates the transcription of proliferation and cilia genes in PANC-1 cells 
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We took a two-step approach to identify direct transcriptional targets of SOX9 in 
PANC-1 cells; namely, RNA-seq following SOX9 knockdown and then ChIP-seq to 
identify SOX9 binding sites. To identify transcripts that are regulated by SOX9 activity, 
we performed RNA-seq in PANC-1 cells that had been transfected with either a SOX9 
siRNA or a control siRNA. Following SOX9 siRNA transfection, SOX9 knockdown was 
confirmed using both Western blotting (Figure 1A) and immunofluorescence of fixed 
cells (Figure 1B). To identify genes regulated by SOX9, we sequenced total RNA 
extracted from PANC-1 cells transfected with either control or SOX9 siRNA and 
identified genes that are differentially expressed between knockdown conditions. We 
identified 93 differentially expressed genes with 60 genes upregulated and 33 
downregulated (Figure 1C; Table 1).  
To confirm the identity of the top differentially expressed genes, we performed 
qRT-PCR in siRNA-treated PANC-1 cells for the top five up- and down-regulated genes. 
In doing so, we confirmed the differential expression of these ten genes, except the 
downregulated gene SKIV2L (Figure 1D). While SKIV2L demonstrated the largest fold 
change of the downregulated genes, it was also nearest the acceptable p-value cut-off and 
thus may be a false positive.  
In order to further validate the differential gene expression results, we analyzed 
publicly available RNA-seq data from 178 pancreatic adenocarcinoma samples in The 
Cancer Genome Atlas. In these samples, SOX9 is highly expressed and as such, we 
expected to observe directions of effect opposite to those observed in our induced 
knockdown experiments. We clustered our differentially expressed genes based on their 
expression patterns in the tumor samples and observe that in general, corroborating our 
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knockdown studies, upregulated genes clustered together and were lowly expressed in the 
tumor samples, and downregulated genes clustered together and with SOX9 and are 
highly expressed (Figure 2A). Furthermore, at an individual gene level, we correlated 
SOX9 expression with each differentially expressed gene to examine how closely the 
genes are co-regulated in these tumor samples and observed there to be a high degree of 
correlation between the differentially expressed genes and SOX9 expression 
(Supplementary Table 1). For example, the upregulated gene with the strongest degree 
of negative correlation with SOX9 expression is CCDC13 (r = -0.50), bolstering our 
observation that SOX9 negatively regulates this gene (Figure 2B). Conversely, 
expression of the downregulated gene, ESRP1, is strongly positively correlated with 
SOX9 expression (r = 0.67), further suggesting that SOX9 positively regulates this gene’s 
expression (Figure 2C). Overall, these data serve to validate observations from our 
genome wide RNA-seq analyses and provide additional support for our observed 
transcriptional targets of SOX9. 
Finally, to assess the biological consequences of these differentially expressed 
genes, we explored their individual functions and gene ontology (GO) terms. Genes that 
are down-regulated following SOX9 knockdown include genes with established roles in 
cancer motility (ESRP159), cell-cell adhesion (TINAGL164,65), obesity and insulin 
resistance (RGCC66), and cancer stem cell maintenance (EPCAM67). Down-regulated 
genes were collectively enriched for biological processes associated with Notch signaling 
and the negative regulation of proliferation (Figure 1E), suggesting a role for SOX9 in 
negatively regulating proliferation.  
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As a whole, upregulated genes were enriched for processes associated with cilia 
development, assembly, and movement (Figure 1F), suggesting that SOX9 typically 
suppresses these processes. Interestingly, the most highly upregulated genes following 
SOX9 knockdown are LRRC6 and SPEF1, which have known roles in regulating primary 
cilia, important features of ductal epithelial cells.68-70 In all, these observations may 
indicate that SOX9 serves to restrict the differentiation of pancreas progenitor cells 
toward an epithelial fate by promoting the expression of genes important for maintaining 
a progenitor status.  
 
SOX9 binding occurs primarily at transcription start sites and regulates pancreatic 
functions 
We next set out to identify putative SOX9-responsive regulatory regions, 
undertaking anti-SOX9 ChIP-seq. Following pull-down, sequencing, and alignment, our 
analysis identified 47,858 SOX9 binding sites in PANC-1 cells. We then analyzed the 
sequence underlying the top 1000 most significant SOX9 binding events to identify 
transcription factor motifs present at these sites. The top enriched motif was a “tail-to-
tail” palindrome with high similarity to the SOX9 consensus motif (Figure 3A). This 
result supports previous observations in chondrocytes that SOX9 can function as a 
homodimer.71 The second highest enriched motif matched the binding sequence for 
FOS::JUN (Figure 3B) which has been previously reported to bind in conjunction with 
SOX9 in chondrocytes.72 Similar to findings from other groups73,74, we observe an 
enrichment of SOX9 binding events at gene promoters (8.8% of SOX9 peaks; Figure 
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3C), with diminishing proportions of SOX9 binding events occurring as the distance to 
the transcriptional start site increases (Figure 3D).  
Next, we sought to interrogate the potential functional outcome of SOX9 binding 
in PANC-1 cells. We performed functional annotation of the genes proximal to SOX9 
binding sites and found many GO biological processes that match with SOX9’s known 
roles (Figure 3E). These include: 1) endocrine pancreas development, reflecting the 
known function of SOX9 activity in the pancreas; 2) stem cell maintenance, reflecting the 
participation of SOX9 in maintaining pancreatic progenitor identity34 and; 3) ossification 
and osteoblast differentiation, which reflects known functions of SOX9 in bone 
development.75,76 Taken collectively, these data suggest that SOX9 acts in PANC-1 cells 
to regulate target genes important to pancreas biology, in a manner consistent with 
previously reported modes of action in chondrocytes. 
 
Direct targets of SOX9 overlap with known pancreatic ductal genes 
 To narrow down the list of differentially expressed genes to those most 
biologically relevant, we combined three datasets: 1) SOX9 binding events from our 
ChIP-seq experiment to identify direct binding targets of SOX9; 2) genes with enriched 
expression in ductal cells (versus acinar or endocrine cells) of the adult zebrafish 
pancreas18 and; 3) genes enriched in zebrafish CACs which can be used as CAC 
markers.33 By combining these three data sets we sought to find genes that were not only 
direct targets of SOX9 – i.e. those that were differentially expressed following SOX9 
knockdown and had a SOX9 binding site proximal to their promoter – but also relevant to 
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the biology of the zebrafish pancreatic ductal cells, and specifically CACs, not just the 
molecular underpinnings of human PANC-1 cells. 
 We observed that the majority of genes upregulated with SOX9 knockdown are 
not direct targets of SOX9 (57% of all upregulated genes and 70% of the top ten are not 
bound by SOX9), while all but one of the top ten genes downregulated with SOX9 
knockdown are direct targets (Table 2), and 64% of downregulated genes overall are 
bound. Several downregulated genes have enriched expression in pancreatic ductal cells 
while the only upregulated gene with ductal expression is LRRC6. Finally, EPCAM 
appears to be a promising candidate gene for further investigation because it is a direct 
target of SOX9, has enriched expression in zebrafish ductal cells, and is a marker of 
CACs (Table 2). 
 
SOX9 directly regulates expression of EPCAM 
 Given its promising expression in zebrafish pancreatic ductal cells, specifically 
CACs, we examined the relationship between SOX9 and EPCAM. EPCAM is a gene 
encoding a transmembrane protein that is a well-known marker of epithelium and has 
roles in the regulation of pancreas progenitor differentiation and cell adhesion.39,67 Traces 
from our RNA-seq and ChIP-seq display the decreased expression of EPCAM with SOX9 
knockdown and a large SOX9 binding peak centered on the EPCAM transcriptional start 
site and promoter (Figure 4A). Additionally, we performed EPCAM and SOX9 antibody 
staining in PANC-1 cells transfected with either control or SOX9 siRNA. In control-
transfected cells, SOX9 was expressed in all cell nuclei and EPCAM was expressed at the 
plasma membrane in all cells, albeit with varying intensity. Following SOX9 knockdown, 
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SOX9 expression was reduced or absent in nuclei, and EPCAM expression was reduced 
or absent (Figure 4B). These results support the conclusion that SOX9 directly regulates 
EPCAM expression in PANC-1 cells. 
 Furthermore, as a preliminary validation of the relevance of this relationship in 
vivo, we examined the co-regulation of SOX9 and EPCAM in the TCGA pancreatic 
adenocarcinoma samples, as above. In doing so, we observe a strong positive correlation 
of SOX9 and EPCAM expression (r = 0.58; Figure 4C), suggesting that in vivo, as well as 
in vitro, SOX9 is a positive regulator of EPCAM expression.  
 
Epcam does not appear to be necessary for normal CAC function 
Because it is a direct target of SOX9 in PANC-1 cells and a CAC marker in the 
adult zebrafish, we wanted to pursue the role of Epcam in the biology of CACs. To do 
this, we used a CRISPR-generated knockout of epcam where there is a 12 base-pair 
deletion at the splice acceptor site of exon 4 (Figure 5A). We were able to phenotype 
epcam mutants by screening for small otoliths at 2 dpf (data not shown), a phenotype that 
has been previously shown in a different epcam knockout model.77 We first looked at the 
gross morphology of the pancreas using the Tg(ela:GFP) line that marks all acinar cells 
of the pancreas. At 4 dpf there appeared to be no difference in size or morphology of the 
pancreas between larvae with small otoliths (representing epcam mutants) and normal 
otoliths (representing epcam heterozygotes and wildtypes) (Figure 5B). Since our 
previous RNA-seq work showed that epcam is specifically a marker of CACs in the 
zebrafish33 we wanted to next look at the morphology and function of CACs in larval 
epcam mutants. We used the Tg(tp1:GFP) line to mark CACs and assessed the number 
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and morphology of these cells. At 5 dpf, both the epcam mutants (screened by small 
otoliths) and the heterozygotes and wildtypes (screened by normal otoliths) had CACs 
with normal morphology – notice how the cells wrap around the head and down the tail 
of the pancreas, each with long extensions (Figure 5C). When these cells are counted 
across samples, the epcam mutants have the same number of CACs as their non-mutant 
siblings (Figure 5D). Finally, we wanted to assess the function of CACs in epcam 
mutants by looking at their ability to differentiate into secondary islets. We have shown 
previously that treatment with the Notch inhibitor RO4929097 causes early development 
of secondary islets from CACs.78 Treatment of both epcam mutants and their non-mutant 
siblings (crossed with a Tg(NeuroD:GFP) line) from 3 to 5 dpf with either RO4929097 
or a DMSO control revealed that all epcam genotypes are able to increase their number of 
secondary islets at 5 dpf with RO4929097 treatment versus DMSO. (Figure 5E). Taken 
together, these data suggest that while epcam is a direct target of SOX9 and a marker of 
CACs, it does not appear to be necessary for the normal biology and function of CACs. 
 
DISCUSSION 
We previously demonstrated that Sox9b functions downstream of both Notch 
signaling and Retinoic Acid signaling in CACs.34  All of these pathways are responsible 
for maintaining the progenitor identity of CACs. Because understanding the balance 
between progenitor maintenance and endocrine differentiation is central to characterizing 
beta-cell neogenesis, we sought to further elucidate the differentiation process by finding 
the downstream targets of Sox9b to better understand how it functions as a central 
transcription factor in CAC progenitor identity. 
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By performing RNA-seq and ChIP-seq on PANC-1 cells we were able to identify 
both direct targets (change in expression with SOX9 knockdown and SOX9 binding peak 
near promoter) and indirect targets (change in expression with SOX9 knockdown but no 
SOX9 binding peak) of SOX9. Because a number of the direct targets – like EpCAM and 
ESRP1 – are associated with epithelial cells, we wondered if a decrease in these genes 
results in an epithelial-to-mesenchymal transition (EMT) and this change in cell state 
alters the overall transcriptional profile of the PANC-1 cells. But simple EMT induction 
does not explain the changes in transcription we saw - looking at EMT markers by 
Western, IF, and qPCR showed that not only was there no EMT, but PANC-1 cells are 
already mesenchymal in nature before SOX9 knockdown (Supplementary Figure 2). So 
a change to a more mesenchymal phenotype is not responsible for the transcriptional 
differences seen in SOX9 knockdown. Because Sox9b is known to help CACs maintain 
their progenitor identity,34 it’s possible that knockdown of SOX9 in PANC-1 cells 
induces differentiation. This idea fits with our RNA-seq results – knockdown of SOX9 
caused an increase in the expression of many ciliary genes which is a known consequence 
of differentiation.79  
GO analysis of genes downregulated with SOX9 knockdown showed that SOX9 
is important for the positive regulation of Notch receptor targets. This aligns well with 
previous research, as the role of SOX9 in mediating the expression of downstream Notch 
signaling targets is well-established.80-83 Understanding this intricate cross-talk between 
SOX9 and Notch will be important to being able to manipulate progenitor differentiation 
to endocrine cells.34,78 
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In comparison to previous work in other cell systems, we were able to easily see 
the SOX9 binding consensus sequence by pulling out the most enriched sequence at 
binding peaks - unlike the results of ChIP-seq performed in hair follicle stem cells.84 
They found that SOX9 was promiscuous in the sequences it bound to and never saw the 
consensus sequence. In addition, we saw that SOX9 preferentially bound to promoters, 
no matter the target gene, unlike what was seen in developing chondrocytes where SOX9 
bound promoters for normal cellular functions and enhancers for chondrocyte-specific 
transcription.85 These differences suggest that SOX9 may vary in how it acts as a 
transcription factor between different cell types. 
The direct targets of SOX9 that we found have some interesting connotations for 
both the ductal nature of CACs and their progenitor role. TINAGL1 is a matricellular 
protein that is known to bind integrins and laminins and is involved in both post-
implantation development in the uterus65,86 and vascular smooth muscle adhesion.64,87,88 
It’s homolog TINAG is important in tubulogenesis in the kidney.89 CACs are known to 
line the branching ducts of the pancreas, so an extracellular molecule important for cell-
adhesion (and the cell-cell signaling that goes along with it) makes biological sense for 
having an important SOX9-mediated role. ESRP1 is a regulator of splicing and is known 
for predicting favorable outcomes in cancer - i.e. its expression (and therefore splicing 
patterns of things like FGFR2) is thought to suppress cancer cell motility and therefore 
metastasis.59,90-92 This would make biological sense in the context of CACs and 
regeneration - expression of Sox9b and therefore ESRP1 could promote the epithelial 
nature of CACs while loss of these proteins would promote a more migratory, 
mesenchymal nature which is necessary for CACs to move to ablated islets and become 
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endocrine cells. All of these genes would be interesting targets to follow up on by 
examining their expression in the zebrafish pancreas, developing knockouts, and 
assessing their importance in CAC maintenance and biology. 
Finally, we showed that SOX9 regulates the expression of EpCAM, a gene that 
encodes a single-pass transmembrane glycoprotein that localizes to tight junctions.39 In 
addition to its role in cell adhesion, EpCAM can also undergo proteolytic cleavage to 
produce intra- and extracellular fragments that participate in signaling and transcriptional 
activation.67 Although EpCAM is expressed broadly in epithelial tissues, higher 
expression is found in cells that are actively undergoing proliferation and differentiation 
events. Thus, EpCAM serves as a marker of stem and progenitor cell populations in the 
intestine, liver, and salivary gland.40-42 It is also expressed in human and murine 
embryonic stem cells, where it may function upstream of the well-known pluripotency 
factors OCT4 and SOX2.93,94 In the human fetal pancreas, EpCAM expression is 
enhanced in progenitor cells that are budding from the ductal epithelium to form new 
endocrine cells.39 In the adult pancreas, it is most highly expressed in intercalated ducts,39 
which closely resemble CACs and have been proposed to serve as an endocrine 
progenitor population during regeneration.11 Intriguingly, transgenic overexpression of 
EpCAM in the mouse pancreas provokes the development of large endocrine 
islets.95  Within the developing zebrafish liver EpCAM is expressed in Notch responsive 
progenitor cells called Biliary Epithelial Cells (BECs) that act as progenitors for 
hepatocytes during liver damage and development.96,97 Many parallels can be drawn 
between BECs and the CACs of the pancreas. These cell types both line ducts, and Notch 
signaling as well as Sox9 play an important role in maintaining the progenitor status of 
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both. Although it seems disheartening that our CRISPR-generated epcam knockout 
zebrafish line does not show an obvious deficit in CAC function, this actually matches 
the phenotype of sox9b heterozygotes. These fish did not have an obvious pancreatic or 
CAC phenotype and therefore we did not see the important role that sox9b played in 
CAC biology until we looked at ablation and regeneration.34 The logical next step in this 
work then is to see whether epcam mutants regenerate faster or slower than their non-
mutant siblings after ablation of beta cells. This will tell us whether epcam is downstream 
of sox9b in its role maintaining CAC identity or whether epcam instead is downstream of 
sox9b in a different biological context. Because EpCAM is expressed in the mammalian 
pancreas and in the CACs of zebrafish, understanding how EpCAM acts downstream of 
Sox9 in the maintenance and identity of endocrine progenitor cells will help us better 
define the mechanisms behind endogenous increases in beta-cell mass. 
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Figure 1. Knockdown of SOX9 results in an increase of ciliary gene expression and a 
decrease in expression of genes negatively regulating proliferation. (A) Western blot 
and (B) immunofluorescence confirms knockdown of SOX9 protein following SOX9 
siRNA treatment. Scale bar is 100 um. (C) A volcano plot of adjusted p-value versus fold 
change upon SOX9 knockdown indicates that 93 genes exhibit significantly altered 
expression (33 decreased and 60 increased). (D) Quantitative PCR confirms all but one 
(SKIV2L) of the top five upregulated and top five downregulated genes observed with 
RNA-seq. 3 biological replicates per gene, error bars represent standard deviation (E) GO 
analysis of downregulated genes reveals a role for SOX9 in Notch signaling as well as in 
the regulation of proliferation. (F) GO analysis of upregulated genes is enriched for 




Figure 2. Expression data from pancreatic adenocarcinoma samples corroborate the 
expression patterns seen in PANC-1 cells. (A) Expression analysis of the TCGA 
pancreatic adenocarcinoma sample data set indicate that upregulated genes identified by 
RNA-seq in PANC-1 cells tend to cluster together and are lowly expressed in these 
samples. Further, downregulated genes identified by RNA-seq in PANC-1 cells tend to 
cluster together and with SOX9 and are highly expressed. (B) At an individual gene level, 
CCDC13, a gene that is upregulated following SOX9 knockdown, is negatively correlated 
with SOX9 expression, suggesting that SOX9 negatively regulates this gene. (C) 
Conversely, ESRP1, a gene that is downregulated following SOX9 knockdown, is 
positively correlated with SOX9 expression, suggesting that SOX9 positively regulates 





Figure 3. Characteristics of SOX9 gene regulation include promoter proximal 
binding and regulation of genes important to pancreatic biology. (A) The most 
common motif seen at SOX9 binding sites is a homodimer of the forward and reverse 
known SOX9 binding sequences (tail to tail). (B) The second most common motif at 
SOX9 binding sites is recognized by FOS::JUN. (C) SOX9 binding is enriched at 
promoters (≤1000 base-pairs upstream of a transcription start site). (D) As distance from 
the transcriptional start site increases, the proportion of SOX9 binding events decreases. 
(E) The nearest genes to SOX9 binding sites are enriched for GO terms related to known 




Figure 4. RNA-seq and ChIP-seq in combination reveal EPCAM to be a direct target 
of SOX9. (A) Traces corresponding to RNA-seq and ChIP-seq reads near the EPCAM 
gene confirm SOX9 knockdown and reveal SOX9 binding at the EPCAM transcription 
start site. (B) Immunofluorescence staining of PANC-1 cells confirms knockdown of 
both SOX9 and EPCAM protein by siSOX9. Scale bar is 100 um. (C) Expression of 
EPCAM and SOX9 in TCGA pancreatic adenocarcinoma samples are positively 




Figure 5. Epcam mutants show no obvious abnormalities in terms of centroacinar 
cell structure and function. (A) CRISPR-generated mutant allele removes splice site at 
the start of exon 4 of epcam. Top sequence is wildtype and bottom sequence is CRISPR-
generated mutant. End of intron in lower case, beginning of exon 4 in upper case, splice 
acceptor site highlighted in green. (B) A Tg(ela:GFP) background in larval zebrafish at 5 
dpf shows very little difference in pancreas size between epcam wildtypes/heterozygotes 
and mutants. (C,D) A Tg(tp1:GFP) background reveals no difference in the morphology 
or number of CACs between epcam wildtype/heterozygote and mutant zebrafish at 5 dpf. 
(E) CACs in epcam mutant zebrafish are still able to differentiate effectively with 
inductive drug treatment (treatment with either DMSO or RO4929097). Normal otoliths 





Supplementary Figure 1. Changes in gene expression from SOX9 knockdown do not 
correspond with changes in cell state. (A) Immunofluorescence for the mesenchymal 
marker vimentin is present uniformly in PANC-1 cells. (B) There is no change in N-
cadherin or E-cadherin expression by Western blot between PANC-1 cells treated with 
siControl versus siSOX9. (C) Quantitative PCR shows that while there is a general 
decrease in expression of FGFR2 with SOX9 knockdown, there is no change in the ratio 
between its splice isoforms or the splice isoforms of FGFR3, indicative of no EMT.60,61 3 











































 Since many patients with Type II diabetes become insulin-dependent in the later 
stages of their disease, finding ways to increase beta-cell mass endogenously is a helpful 
path to pursue for better diabetes treatments. To do this, we need to understand the 
mechanisms by which beta cells proliferate and see if we can induce these pathways in 
vivo. Two independent studies found that selective serotonin reuptake inhibitors (SSRIs) 
increase beta-cell proliferation.98,99 One, using high throughput screening in larval 
zebrafish, found that paroxetine (Paxil) induced beta-cell proliferation and confirmed that 
another SSRI, fluoxetine (Prozac) as well as serotonin (5HT) itself increased beta-cell 
proliferation.98 The other used juvenile fish of the FUCCI transgenic line and discovered 
that two different serotonin uptake inhibitors, Trazadone and Lofepramine, increased 
beta-cell proliferation.99 These results make serotonin signaling to zebrafish beta cells an 
interesting candidate to study for manipulation of beta-cell proliferation. 
 Serotonin has been implicated before in processes outside the brain. For example, 
in zebrafish, tph1b, the rate limiting enzyme in serotonin synthesis from tryptophan, is 
expressed in connective tissue progenitor cells after amputation of the tail fin.100 
Serotonin has been shown to be produced by human beta cells in order to communicate 
with alpha cells to better control blood glucose.101 In addition, serotonin has been seen in 
mammals to induce beta-cell proliferation during pregnancy – the beta cells of pregnant 
mice synthesize serotonin, release that serotonin, and it feeds back on serotonin receptors 
on beta cells themselves to induce cell cycle progression as well as increasing glucose-
stimulated insulin secretion.102,103 
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 Since RNA-seq work that has been previously published suggests that zebrafish 
beta cells do not express any isoform of tryptophan hydroxylase,18 which is necessary for 
serotonin synthesis,104 zebrafish beta cells must not be able to synthesize and release their 
own serotonin. We had two main hypotheses for where this source of serotonin signaling 
to the larval zebrafish principal islet could be – either serotonergic neurons 
communicating with the islet by innervation or neuroendocrine cells releasing serotonin 
into the bloodstream. Multiple types of innervation to the pancreas is well-studied in 
mammals. Sympathetic and parasympathetic innervation from the autonomic nervous 
system is known to influence both beta-cell mass and glucose-stimulated insulin 
secretion.105-107 And loss of sympathetic nerves to the islets has been associated with 
Type I diabetes.108 Innervation by both sensory nerves106 and the enteric nervous 
system109 has also been established in the mammalian pancreas. Since innervation to the 
pancreas has been characterized in mammalian systems, we decided to start here in 
looking for how a serotonergic signal is communicated to the zebrafish principal islet. 
 We were able to establish that, as in mammals, there is innervation of the larval 
zebrafish principal islet. Using the colourless mutant line as a model of reduced 
innervation to the islet, we tested whether this innervation was necessary to see 
proliferation of beta cells in response to an SSRI. Surprisingly, beta cells increased their 
proliferation in response to Paxil even in the mutant larvae with greatly reduced 
innervation. This raises some interesting questions about how serotonergic signaling to 
the pancreas works in zebrafish and whether we are able to use that system as a way to 




Zebrafish husbandry and lines 
Zebrafish were maintained in system water according to standard methods 
(Westerfield, 2007). All work involving zebrafish was reviewed and pre-approved by the 
institutional care and use committee. The following previously published lines were used 
for experiments: Tg(ptf1a:GFP),110 Tg(NeuroD:GFP),63 sox10 mutant line (colourless, t3 
allele),111,112 Tg(ins:hmgb1-GFP),62 Tg(-28.5sox10:cre; elfa:flox-dsRed-flox-GFP) 
(known as sox10 lineage tracing), and Tg(tph2:epNTR-RFP)jf41.113 
 
Drug treatment 
 Paxil (paroxetine hydrochloride hemihydrate Sigma Aldrich P9623) was stored at 
10 mM in DMSO at -20 °C and diluted to 10 uM in E3 for treatment. 100% DMSO was 
stored at room temperature and diluted to 0.1% in E3 for treatment. Edu (5-Ethynyl-2’-
deoxyuridine Sigma Aldrich 900584) was stored at 10 mM in PBS at -20 °C and diluted 
to 500 uM in E3 for treatment. For their 48-hour treatment, larvae were divided into a 24-
well plate with a maximum of 5 fish per well. E3 with Edu and either Paxil or DMSO at 
the above concentrations was added. Plates were kept protected from light and in an 
incubator at 29 °C for 48 hours. The larvae were then immediately fixed as described 
below. 
 
Staining and imaging of pancreata 
 Larvae were fixed in 4% PFA (diluted from 32% in PBS) in glass vials at 4 °C 
from overnight to a maximum of 2 days. PFA was removed and larvae were rinsed two 
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times with PBST. The pancreas with the gut attached was dissected out from individual 
larvae by first removing the head and tail using a razor blade on top of a glass coverslip, 
then putting these midbodies into PBST overlying a layer of 1% agarose. The gut and 
pancreas were dissected out using pulled glass needles. These samples were then 
optionally rinsed one time in 100% MeOH and stored in 100% MeOH at -20 °C until 
staining continued (except for the Edu staining in which case this is a necessary step). As 
adapted from Kimmel and Meyer,114 if samples were stored in MeOH, samples were 
rehydrated with 5 min incubations in 75% MeOH/25% PBST, then 50% MeOH/50% 
PBST, then 25%MeOH/75% PBST, then 3 washes in PBST. Samples were incubated at 
room temperature for 20 minutes in 1% DMSO/0.5% Triton (in PBS) and washed with 
PBST. For Edu staining, the Click-It reaction was then performed by combining reagents 
from the Click-iT Edu Alexa Fluor 647 Imaging Kit (Invitrogen C10340) as per Kimmel 
and Meyer,114 adding 100 uL (per 1.5 mL Eppendorf) of the staining solution to the 
samples after removing as much PBST as possible, and incubating for 2 hours in the dark 
at room temperature. Samples were rinsed 3 times in PBST and then blocked for at least 
one hour at room temperature (protected from light as the Click-It reaction is light 
sensitive) in either 1% DMSO / 1% Triton / 2% Goat Serum / 0.1% BSA (in PBS) or 1% 
DMSO / 1% Triton / 5% Goat Serum (in PBS) depending on the quality of the BSA 
(some types react with secondary antibodies). Samples were then incubated overnight at 
4 °C in primary antibody diluted in blocking solution as per Supplementary Table 1. 
Samples were then washed in either 1% BSA / 0.3% Triton (in PBS) or PBST (depending 
on the quality of the BSA – see above) 6 times at room temperature for 15 minutes each 
and then incubated overnight at 4 °C in secondary antibody diluted in blocking solution 
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as per Supplementary Table 1. Samples were washed 6 times at room temperature for 
15 minutes each in PBST and then mounted for imaging by placing each sample onto a 
glass coverslip using forceps, letting excess PBST evaporate, sealing the coverslip to a 
slide using vacuum grease, then adding back water and sealing the outside with 
fluorescence mounting media (Dako S3023). 
 Samples were imaged on a Nikon A1-si Laser Scanning Confocal microscope and 
when necessary cells were counted using ImageJ. All images in figures are maximum 
intensity projections of the Z-stacks collected. Analysis of the percent volume of 
innervation per islet was performed using IMARIS – briefly, the outline of the principal 
islet in a Z-stack projection was identified by hand and IMARIS was used to calculate the 
volume of that islet and recognize and calculate the volume of the acetylated tubulin 
staining within the islet. The ratio of acetylated tubulin volume / islet volume (times 100 
to get the percentage) is represented in the figure. 
 
RESULTS 
Because of our interest in 5HT signaling to the pancreas and the fact that the gut 
is the largest producer of 5HT in the body,115 we wanted to know if we could manipulate 
serotonergic neurons in the gut. A recent publication suggested that 5HT+ positive 
neurons in the gut are also ptf1a+.116 But when we did our own staining of guts from 
Tg(ptf1a:GFP) fish we saw that while there are 5HT+ positive cells in the gut wrapped 
with axons (marked by acetylated tubulin staining) that are assumedly serotonergic 
neurons (Figure 1A,B), these cells do not overlap with ptf1a expression (Figure 1C). 
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Even though we don’t have an easy marker for serotonergic neurons in the gut, 
we wanted to move forward with the hypothesis that these cells are the source of 5HT 
signaling to the pancreas. In order for serotonergic neurons in the gut to signal the islet, 
the islet of the zebrafish has to be innervated. To look at the presence of innervation in 
the zebrafish principal islet we used the Tg(NeuroD:GFP) line to mark all endocrine 
cells, and therefore visualize the entire principal islet, and acetylated tubulin staining to 
mark axons. At 2 days post fertilization (dpf), there is acetylated tubulin staining running 
next to the principal islet but not within (Figure 2A). The small amount of red staining 
seen within the islet is because acetylated tubulin also marks cilia and beta cells are 
ciliated. In comparison, at 4 dpf there is now a larger bundle of nerves running at the 
junction between the gut and the pancreas (see white arrows) and a large amount of 
innervation, marked by red acetylated tubulin staining, within the principal islet (Figure 
2B). This timing of innervation is consistent with a recently published similar study.117 
Because previously we’ve seen SSRIs and serotonin itself able to induce beta-cell 
proliferation between 3 and 5 dpf,98 the presence of innervation of the principal islet 
appearing by 4 dpf is consistent with the hypothesis that innervation of the islet is a 
possible source of serotonin signaling. 
When we looked later in development, endocrine cells differentiating first and 
then innervation following was also true in the case of secondary islets. Using the same 
Tg(NeuroD:GFP) line to mark endocrine cells and acetylated tubulin staining to show 
axons, we saw that at 6 dpf secondary islets were present, the principal islet was highly 
innervated, but there was no acetylated tubulin staining in the secondary islets (shown 
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best in the magnified inset) (Figure 2C). By 7 dpf, the secondary islets were innervated, 
shown by acetylated tubulin staining through the secondary islet (Figure 2D).  
Since we now know that the principal islet of the zebrafish is innervated, we next 
wanted to see whether this innervation was necessary for the proliferative effects of Paxil. 
In order to do this, we needed a model without innervation of the pancreas. We turned to 
the well-described sox10 mutant zebrafish, known as colourless, in which neural crest 
cells apoptose as they migrate, which should result in a lack of an enteric nervous 
system.118  In order to look at innervation in sox10 mutant zebrafish we bred in the 
Tg(ins:hmgb1-GFP) line that marks beta-cell nuclei and then stained for acetylated 
tubulin as a marker for axons. Instead of genotyping the larvae of a sox10+/- incross, we 
phenotyped using the fact that homozygous mutants lack melanocytes and are therefore 
completely colorless.118 Anything that lacked melanocytes at 2 dpf or later was deemed 
sox10-/-, or homozygous mutant, and anything with the normal melanocyte pattern was 
deemed sox10+/?, which represents a mix of sox10 heterozygotes and wildtypes. When 
we examined innervation by acetylated tubulin staining at 5 dpf, we saw that while 
innervation was present in the gut of both sox10 mutants and their non-mutant siblings, 
innervation to the principal islet (marked by the green nuclei of beta cells from 
Tg(ins:hmgb1-GFP)) was markedly reduced in the sox10 mutants (Figure 3A,B). This 
can be seen especially well when only the acetylated tubulin channel is visualized 
(Figure 3A, B, right panels). We then quantified this difference in innervation between 
mutants and their non-mutant siblings using IMARIS to calculate the percent of the 
principal islet that was innervation by volume. This quantification confirmed that sox10-/- 
larvae have a significantly reduced innervation of the principal islet at 5 dpf (Figure 3C). 
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This reduction in innervation in sox10 mutants has also been confirmed independently in 
a recent publication.117  
These sox10-/- mutants seemed like a good model to test the necessity of 
innervation for the effects of Paxil, but we needed to make sure that a reduction in 
innervation to the principal islet was the only pancreas phenotype of sox10-/- mutants. If 
the loss of sox10 caused another functional problem with the islet, that could skew the 
results we get in terms of the effect of Paxil on beta cells. To get an idea of the role of 
sox10-derived cells in the pancreas we used the lineage tracing line Tg(-28.5sox10:cre ; 
elfa:flox-dsRed-flox-GFP). In this line, any cell that ever expresses sox10 will then 
express GFP and so will all of its progeny. When we looked at the gut and the pancreas at 
5 dpf, we saw many sox10-derived cells closely associated with the enteric nervous 
system, marked by acetylated tubulin staining (Figure 4A). These sox10-derived cells 
were also present and closely associated with axons where innervation branched off into 
the pancreas (Figure 4B). Finally, we sometimes saw sox10-derived cells actually 
adjacent to the principal islet, marked by insulin staining in white, although this was a 
rare phenomenon (Figure 4C).  
Because Schwann cells are neural crest-derived and sox10 is an important 
transcription factor in neural crest cell survival, we hypothesized that these sox10-derived 
cells we saw adjacent to the principal islet were part of a Schwann cell sheath. A 
Schwann cell sheath around islets has been described previously in mammals119,120  but 
never in zebrafish. We used the Tg(ins:hmgb1-GFP) line to show beta-cell nuclei and 
S100ß staining as a marker of both myelinating and unmyelinating Schwann cells. In 
both sox10 mutants and their non-mutant siblings, there are Schwann cells surrounding 
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the principal islet at 5 dpf (Figure 4D,E). This means that even though sox10 mutant 
zebrafish lose some of their neural crest cells by apoptosis, there is a compensating factor 
so that important neural crest-derived components like a Schwann cell sheath around the 
principal islet are still present. Interestingly, in some samples it looked like this Schwann 
cell sheath was in the process of degradation (Supplementary Figure 1). This 
phenomenon was much more common in sox10-/- larvae than their non-mutant 
counterparts. It will be interesting to follow up on whether this is an antibody artifact or 
real degradation of the Schwann cell sheath that might be linked to the amount of 
innervation to the principal islet. We did confirm that this S100ß staining was not a non-
specific marker of another endocrine cell type by showing there is no overlap between 
anti-GFP and anti-S100ß staining in the principal islets of Tg(NeuroD:GFP) larvae 
(Supplementary Figure 2). We should investigate though whether these sox10+ positive 
cells could be neurons as a recent publication described sox10-derived migrating neurons 
surrounding the principal islet early in development that are necessary for establishing 
innervation of the islet.117 
Since we confirmed that sox10 mutant zebrafish have reduced innervation of the 
principal islet compared to their non-mutant siblings and that they appear to still retain 
other important neural crest-derived components in the pancreas like the Schwann cell 
sheath surrounding the principal islet, we can use this model to test whether innervation 
is necessary for the proliferative effects of Paxil. We again used the Tg(ins:hmgb1-GFP) 
line to mark beta-cell nuclei. Larvae were screened for their sox10 phenotype at 2 dpf and 
then treated from 3 dpf to 5 dpf with either 0.1% DMSO or 10 uM Paxil as well as Edu 
(Figure 5A). Any cells that proliferated during this 48-hour time period will have taken 
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up Edu and therefore can be stained and marked as proliferating. When the principal 
islets were imaged after this 2-day treatment, we saw that in both the sox10 mutants and 
their non-mutant siblings there were more cells with overlapping GFP and Edu staining 
when the larvae had been treated with Paxil versus DMSO (Figure 5B). Although there 
was a high level of variation within each genotype and treatment in terms of the number 
of proliferating cells, quantifying across samples shows this statistically significant 
increase in the number of proliferating beta cells in both sox10-/- and sox10+/? larvae when 
treated with Paxil versus DMSO (Figure 5C). 
 
DISCUSSION 
 By using the sox10 mutant model we were able to better understand the 
relationship between innervation to the principal islet of the zebrafish and the effect of 
SSRIs on beta-cell proliferation – while sox10 mutant zebrafish have greatly reduced 
innervation to the islet, their beta cells still proliferate in response to Paxil. This result 
leads us in two different directions – whether sox10 is truly the right model to assess the 
question, and then what other sources of serotonin to the pancreas might be. 
 When we examined innervation to the principal islet of sox10 mutants at 5 dpf, 
we saw that while that innervation was greatly reduced, there were still some residual 
nerve fibers (Figure 5). It is possible that this small amount of remaining innervation is 
enough to communicate a serotonergic signal and so these nerves are truly necessary for 
the effects of SSRIs on beta cells. In order to test this, we need a more complete model of 
loss of innervation to the islet. The first promising lead for an absolute lack of innervation 
is the tfap2a;foxd3 double mutant. It has been described that while individual mutants for 
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these genes have a partial reduction in neural crest-derived cells, the double mutant has a 
complete loss of neural crest cells early on in development resulting in a variety of 
defects including loss of melanocytes, malformed craniofacial structure, and a complete 
absence of peripheral neurons, including the enteric nervous system.121  
 Another mutant line to assess in the future is the ret heterozygous mutant line. 
This fish is a model of the human Hirschsprung Disease in which neural crest cells are 
unable to populate the developing gut and therefore there is no enteric nervous system. It 
has been found that ret is required in a dose-dependent manner for the enteric nervous 
system to exist normally122 and that ret heterozygous mutants have a reduced enteric 
nervous system that can become even more severely reduced by crossing with a mapk10 
mutant line.123 Both this mutant line and the tfap2a;foxd3 mutant line should be assessed 
in the future for whether there is a more complete loss of innervation of the principal islet 
than what we saw in the sox10 mutants. If we still see the proliferative effects of Paxil on 
beta cells when there is an absolute loss of innervation, then we can say with more 
confidence that innervation (and therefore serotonergic neurons of the gut) is not the 
source of serotonin signaling to the pancreas. 
 If the nervous system is not responsible for conveying a serotonin signal to the 
pancreas, the next candidate to check is the circulatory system, specifically that serotonin 
is produced by enterochromaffin cells in the gut and travels as an endocrine hormone 
through the blood to reach the principal islet. Enterochromaffin cells are a specialized 
population of enteroendocrine cells that reside amongst the epithelial enterocytes of the 
gut.124 These cells express TPH1 (in mammals), synthesize serotonin, and release that 
serotonin into the circulatory system.124-126 While very well characterized in mammals, 
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the role of enterochromaffin cells, and genes we can use as their markers, are not well 
characterized in the zebrafish. It has been shown previously that the fate of secretory cells 
(versus enterocytes) in the zebrafish gut is dependent on inhibition of Notch signaling by 
microbiota127 and also the acheate-scute like family member ascl1a.128 In addition, 
enteroendocrine cells in general express nkx2.2a.127 If we can better characterize 
enterochromaffin cells in zebrafish, then we can manipulate them to understand their role 
in serotonergic signaling to the pancreas.  
Enterochromaffin cells must express one of the zebrafish isoforms of tryptophan 
hydroxylase which performs the rate-limiting step in the synthesis of 5HT from 
tryptophan.104 We saw no tph2 expression in the gut (Supplementary Figure 3), leaving 
only the isoforms tph1a and tph1b to pursue further. If we can establish one of these 
genes as a marker for enterochromaffin cells in the zebrafish gut and manipulate them 
using an MTZ/NTR ablation system,32 for example, we could establish if they are the 
source of serotonergic signaling to the principal islet. Since enterochromaffin cells 
release serotonin into the blood, we can also test whether the circulatory system is 
necessary for the effects of Paxil. The well-characterized cloche mutant line lacks many 
parts of the circulatory system, including blood vessels to the pancreas,129 because cloche 
is necessary for the differentiation of endothelial cells.130,131 This lack of blood supply to 
the islet could help us understand whether 5HT is acting as a hormone being transported 
by blood to beta cells. Finally, if it is the circulatory system that is supplying 5HT to the 
islet to have an effect on beta cells, they should express serotonin receptors to respond. 
We are currently working on developing and characterizing a CRISPR-generated mutant 
of htr2b which is the only serotonin receptor expressed in the zebrafish beta cell (at least 
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in adults),18 to see whether it is necessary for responding to Paxil. All of the above 
proposed experiments will help hone in on the mechanism by which serotonin signaling 
affects the principal islet. 
Even if we understand how SSRIs are able to have an effect on beta cells in 
zebrafish, there is still the question of whether this will translate to humans. There have 
been several recent studies looking both retrospectively at medical records and also 
working with cell culture to try to understand the effect of SSRIs on diabetes in a clinical 
setting. Retrospective studies have actually linked prolonged use of SSRIs, especially in 
young adults, with an increased risk of developing Type II Diabetes.132,133 And another 
study found that in diabetic patients, SSRI use was associated with an increased risk of 
becoming insulin dependent.134 Experiments conducted in cell culture suggested that 
SSRIs cause reduced glucose-stimulated insulin secretion from beta cells, as well as other 
functional issues in beta cells like problems with cell-cell adhesion, decreased calcium 
release, increased oxidative damage, and increased apoptosis.135-137 But there are other 
retrospective studies that conflict with these results – one that suggests that the link seen 
between diabetes risk and SSRI use is not causal because they saw no difference in either 
fasting plasma glucose or HbA1c between patients who did or did not take 
antidepressants.138 And finally, several studies actually recommend the use of SSRIs in 
patients with diabetes and comorbid depression because the use of antidepressants is 
associated with both a decrease in depressive symptoms as well as better indices of 
glycemic control like fasting glucose and HbA1c.139-141 Taken together, these studies 
suggest that while long-term use of antidepressants is associated with an increased risk of 
diabetes, this may not be causal and retrospective studies do not have the nuance to be 
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able to separate out the mental health symptoms, intended and side effects of SSRIs, and 
metabolic disease. If we can better understand the mechanism behind serotonergic 
signaling to beta cells in the zebrafish, maybe we can bypass the use of an SSRI and 
instead find a drug with a more direct effect and fewer complicating side effects. 
Finally, there is the interesting question of what the role of serotonergic signaling 
to the pancreas was originally intended for in the zebrafish. If this signaling is coming 
from the gut, it could be a way for the gut to communicate with the endocrine cells of the 
islet post-prandially in preparation for the insulin that will be required for increased blood 
sugar after a meal. There are a few established facts that support this hypothesis. It is 
known that feeding, and especially over-nutrition, causes an increase in beta-cell number 
in the larval zebrafish.142 In addition, enterochromaffin cells will release serotonin after a 
meal.143 And finally, there is recent work showing a link between enterochromaffin cells 
and beta cells – microbiota in the gut are necessary for the normal development of both 
the principal islet and secretory cells of the zebrafish gut.127,144 Taken together, these data 
suggest the interesting hypothesis that there is a communication between 
enterochromaffin cells and beta cells post-prandially to better control the rise in blood 
sugar after food intake. 
In conclusion, we saw that although the zebrafish principal islet is innervated, this 
innervation is not necessary for the proliferative effect that SSRIs have on beta cells. 
Future work needs to define the mechanism by which serotonergic signaling to the 
pancreas happens so that eventually we can target it as a means of increasing beta-cell 
number in the clinic. 
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Figure 1. Serotonergic neurons in the gut are not ptf1a+ (A) Tail of the gut from a 5 
dpf Tg(ptf1a:GFP) zebrafish larva. Blue is DAPI staining, green is anti-GFP, red is anti-
5HT, white is anti-acetylated tubulin (as a marker for axons). (B) Same as above but 
without DAPI for a clearer view of acetylated tubulin. Yellow arrows mark 5HT+ cells 
wrapped in acetylated tubulin, representing serotonergic neurons. (C) Same as (A) but 





Figure 2. Innervation of islets appears after differentiation. All larvae are 
Tg(NeuroD:GFP). Blue is DAPI, green is anti-GFP, red is anti-acetylated tubulin (A) 
Principal islet from a 2 dpf larva. Note the lack of innervation (acetylated tubulin 
staining) within the islet. (B) Principal islet from a 4 dpf larva. Note the large amount of 
acetylated tubulin staining, representing innervation, within the islet. White arrows mark 
acetylated tubulin staining running along the junction between the pancreas and the gut. 
(C) Gut and pancreas from a 6 dpf larva. A secondary islet is circled and the inset is a 
slightly zoomed view to show lack of acetylated tubulin staining. (D) Gut and pancreas 
from a 7 dpf larva. A secondary islet is circled and the inset is a slightly zoomed view to 





Figure 3. sox10 mutant larvae have reduced innervation compared to their non-
mutant siblings. Both larvae are Tg(ins:hmgb1-GFP). Green is anti-GFP, red is anti-
acetylated tubulin (A) The principal islet from a sox+/? (either heterozygous or wildtype) 
larva at 5 dpf. The panel on the right is showing just acetylated tubulin staining. Note the 
large amount of innervation to the principal islet. (B) The principal islet from a sox10-/- 
larva at 5 dpf. The panel on the right is showing just acetylated tubulin staining. Note the 
greatly reduced amount of innervation compared to the non-mutant larva. (C) 
Quantification of the amount of innervation to the principal islet at 5 dpf (percent by 
volume). Each dot represents the percent innervation from the islet of an individual larva 




Figure 4. sox10-derived cells are rarely in the pancreas and all sox10 genotypes have 
a Schwann cell sheath. (A) The gut and pancreas from a 5 dpf sox10 lineage tracing 
larva. Green is anti-GFP (sox10+), red is anti-acetylated tubulin, white is anti-insulin. 
The pancreas is outlined in yellow. Notice the association of sox10+ cells with the enteric 
nervous system. (B) Close-up of the principal islet from the same line and staining as 
above. Notice the sox10+ cells associated with the axons branching into the islet. (C) 
Same as (B). Note the presence of sox10+ cells around the principal islet. (D) Principal 
islet from a 5 dpf Tg(ins:hmgb1-GFP) larva that is not mutant for sox10 (sox10+/?). Green 
is anti-GFP and red is anti-S100ß (Schwann cell marker). There appears to be a Schwann 
cell sheath surrounding the principal islet. (E) Principal islet from a 5 dpf Tg(ins:hmgb1-
GFP) larva that is sox10-/-. Note that a Schwann cell sheath is present in this sox10 





Figure 5. sox10-/- larvae are still able to respond to Paxil treatment with beta-cell 
proliferation. (A) Timeline of the experiment showing when fish were crossed, screened, 
treated, and fixed for assessment. Dpf is days post fertilization. (B) Principal islets from 
sox10+/? and sox10-/- larvae (in Tg(ins:hmgb1-GFP)) treated with either 0.1% DMSO or 
10 uM Paxil. Blue is DAPI, green is anti-GFP, red is Edu. Note the increased amount of 
yellow (overlap of green and red) in both larvae treated with Paxil (versus DMSO). (C) 
Quantification of the number of Edu+ (proliferating) beta cells per principal islet. 
Genotype and treatment is listed on the X-axis. Each dot represents the result from a 
principal islet from an individual larva. Samples are combined from fish treated on 4 




Supplementary Figure 1. Principal islet from a sox10-/- ; ins:hmgb1-GFP  larva at 5 dpf. 
Green is anti-GFP and red is anti-S100ß. Note the messy staining that looks like 





Supplementary Figure 2. Principal islet from a Tg(NeuroD:GFP) larva at 5 dpf. Green 
is anti-GFP, red is anti-S100ß, white is anti-insulin. (A) Note how NeuroD+ cells do not 
overlap with S100ß staining, shown with yellow arrows. (B) Note how in the same 
principal islet insulin staining does overlap with NeuroD+ cells, as expected because 





Supplementary Figure 3. (A) brain and (B) gut and pancreas from a 5 dpf 
Tg(tph2:epNTR-RFP)jf41 larva. Blue is DAPI and red is anti-DsRed. Pancreas is outlined 
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